Cargando…

Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells

BACKGROUND: Epithelial ovarian cancer (EOC) cells are prone to metastasise throughout the peritoneal cavity. The epithelial-to-mesenchymal transition (EMT) is a necessary step towards metastatic tumour progression. CA125/MUC16 mucin is a high-molecular-weight glycoprotein overexpressed in the majori...

Descripción completa

Detalles Bibliográficos
Autores principales: Comamala, M, Pinard, M, Thériault, C, Matte, I, Albert, A, Boivin, M, Beaudin, J, Piché, A, Rancourt, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065274/
https://www.ncbi.nlm.nih.gov/pubmed/21326240
http://dx.doi.org/10.1038/bjc.2011.34
_version_ 1782200960375848960
author Comamala, M
Pinard, M
Thériault, C
Matte, I
Albert, A
Boivin, M
Beaudin, J
Piché, A
Rancourt, C
author_facet Comamala, M
Pinard, M
Thériault, C
Matte, I
Albert, A
Boivin, M
Beaudin, J
Piché, A
Rancourt, C
author_sort Comamala, M
collection PubMed
description BACKGROUND: Epithelial ovarian cancer (EOC) cells are prone to metastasise throughout the peritoneal cavity. The epithelial-to-mesenchymal transition (EMT) is a necessary step towards metastatic tumour progression. CA125/MUC16 mucin is a high-molecular-weight glycoprotein overexpressed in the majority of serous carcinomas, suggesting a possible role in the pathogenesis of these cancers. METHODS: The role of CA125/MUC16 in EMT was investigated using single-chain antibody-mediated knockdown of cell surface CA125/MUC16 in overexpressing EOC NIH:OVCAR3 cells. RESULTS: CA125/MUC16 knockdown was associated with morphological alterations along with decreased surface expression of epithelial markers (E-cadherin, cytokeratin-18) and increased expression of mesenchymal markers (N-cadherin, vimentin). Co-immunoprecipitation experiments revealed that CA125/MUC16 binds to E-cadherin and β-catenin complexes. The in vitro studies showed disruption of cell–cell junctions, enhanced motility, migration and invasiveness in CA125/MUC16 knockdown cells. Enhanced epidermal growth factor receptor (EGFR) activation was observed in CA125/MUC16 knockdown cells along with increased Akt and ERK1/2 phosphorylation, which are downstream effectors of EGFR, and increased MMP-2 and MMP-9 expression and activities. Epidermal growth factor receptor inhibition strongly inhibited the motility of CA125/MUC16 knockdown cells. CONCLUSIONS: Our findings suggest that CA125/MUC16 plays a role in EMT, presumably through its interaction with E-cadherin and β-catenin complexes and by modulating EGFR and its downstream signalling pathway in NIH:OVCAR3 cells.
format Text
id pubmed-3065274
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-30652742012-03-15 Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells Comamala, M Pinard, M Thériault, C Matte, I Albert, A Boivin, M Beaudin, J Piché, A Rancourt, C Br J Cancer Molecular Diagnostics BACKGROUND: Epithelial ovarian cancer (EOC) cells are prone to metastasise throughout the peritoneal cavity. The epithelial-to-mesenchymal transition (EMT) is a necessary step towards metastatic tumour progression. CA125/MUC16 mucin is a high-molecular-weight glycoprotein overexpressed in the majority of serous carcinomas, suggesting a possible role in the pathogenesis of these cancers. METHODS: The role of CA125/MUC16 in EMT was investigated using single-chain antibody-mediated knockdown of cell surface CA125/MUC16 in overexpressing EOC NIH:OVCAR3 cells. RESULTS: CA125/MUC16 knockdown was associated with morphological alterations along with decreased surface expression of epithelial markers (E-cadherin, cytokeratin-18) and increased expression of mesenchymal markers (N-cadherin, vimentin). Co-immunoprecipitation experiments revealed that CA125/MUC16 binds to E-cadherin and β-catenin complexes. The in vitro studies showed disruption of cell–cell junctions, enhanced motility, migration and invasiveness in CA125/MUC16 knockdown cells. Enhanced epidermal growth factor receptor (EGFR) activation was observed in CA125/MUC16 knockdown cells along with increased Akt and ERK1/2 phosphorylation, which are downstream effectors of EGFR, and increased MMP-2 and MMP-9 expression and activities. Epidermal growth factor receptor inhibition strongly inhibited the motility of CA125/MUC16 knockdown cells. CONCLUSIONS: Our findings suggest that CA125/MUC16 plays a role in EMT, presumably through its interaction with E-cadherin and β-catenin complexes and by modulating EGFR and its downstream signalling pathway in NIH:OVCAR3 cells. Nature Publishing Group 2011-03-15 2011-02-15 /pmc/articles/PMC3065274/ /pubmed/21326240 http://dx.doi.org/10.1038/bjc.2011.34 Text en Copyright © 2011 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Molecular Diagnostics
Comamala, M
Pinard, M
Thériault, C
Matte, I
Albert, A
Boivin, M
Beaudin, J
Piché, A
Rancourt, C
Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells
title Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells
title_full Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells
title_fullStr Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells
title_full_unstemmed Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells
title_short Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells
title_sort downregulation of cell surface ca125/muc16 induces epithelial-to-mesenchymal transition and restores egfr signalling in nih:ovcar3 ovarian carcinoma cells
topic Molecular Diagnostics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065274/
https://www.ncbi.nlm.nih.gov/pubmed/21326240
http://dx.doi.org/10.1038/bjc.2011.34
work_keys_str_mv AT comamalam downregulationofcellsurfaceca125muc16inducesepithelialtomesenchymaltransitionandrestoresegfrsignallinginnihovcar3ovariancarcinomacells
AT pinardm downregulationofcellsurfaceca125muc16inducesepithelialtomesenchymaltransitionandrestoresegfrsignallinginnihovcar3ovariancarcinomacells
AT theriaultc downregulationofcellsurfaceca125muc16inducesepithelialtomesenchymaltransitionandrestoresegfrsignallinginnihovcar3ovariancarcinomacells
AT mattei downregulationofcellsurfaceca125muc16inducesepithelialtomesenchymaltransitionandrestoresegfrsignallinginnihovcar3ovariancarcinomacells
AT alberta downregulationofcellsurfaceca125muc16inducesepithelialtomesenchymaltransitionandrestoresegfrsignallinginnihovcar3ovariancarcinomacells
AT boivinm downregulationofcellsurfaceca125muc16inducesepithelialtomesenchymaltransitionandrestoresegfrsignallinginnihovcar3ovariancarcinomacells
AT beaudinj downregulationofcellsurfaceca125muc16inducesepithelialtomesenchymaltransitionandrestoresegfrsignallinginnihovcar3ovariancarcinomacells
AT pichea downregulationofcellsurfaceca125muc16inducesepithelialtomesenchymaltransitionandrestoresegfrsignallinginnihovcar3ovariancarcinomacells
AT rancourtc downregulationofcellsurfaceca125muc16inducesepithelialtomesenchymaltransitionandrestoresegfrsignallinginnihovcar3ovariancarcinomacells